In this model, treatment with OPN-neutralising antibodies abrogated B-ALL/BM-MSC adhesion and increased tumour cell Ki67 expression and BM tumour burden, supporting the conclusion that OPN contributes to the quiescence of B-ALL blasts within the BM. The gene discussed is MKI67; the disease is acute lymphoblastic leukemia.